| Nov 13 |
Shuttle Pharma Provides Third Quarter 2024 Corporate Update
|
| Oct 30 |
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
|
| Oct 30 |
Shuttle Pharmaceuticals dips 6%, prices $4.5M share offering
|
| Oct 30 |
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
|
| Oct 29 |
Shuttle Pharma Pays Off Senior Secured Convertible Note
|
| Oct 29 |
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
|
| Oct 29 |
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
|
| Oct 28 |
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
|
| Oct 28 |
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024
|
| Sep 20 |
Shuttle Pharmaceuticals files for offering common stock, warrants
|
